Genomes Sequenced for Every US and Canada Butterfly

Researchers analyzed more than 800 species.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, PHOTODEER

Ateam of researchers led by evolutionary biologist Nick Grishin at the University of Texas Southwestern Medical Center in Dallas has sequenced the genomes of all butterfly species in the US and Canada, according to a preprint published November 4 on bioRxiv.

Grishin’s team collected butterflies in the wild and also worked with museums and butterfly enthusiasts to obtain genetic material from all 845 butterfly species north of Mexico. Once the researchers had sequenced each genome, they constructed an evolutionary tree based on differences in protein-coding genes. The tree was largely in agreement with previous evolutionary groupings, but the team suggested reclassifying 40 butterfly species at the genus level, reports Nature.

They also found that some groups of butterfly species that evolved faster than others may have done so through interactions with other species that helped the butterflies thrive. For example, Polyommatinae, a group of blue butterflies, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development